Zobrazeno 1 - 10
of 1 734
pro vyhledávání: '"Lymphoplasmacytic lymphoma"'
Autor:
Oliver Tomkins, Shirley D’Sa
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Lymphoplasmacytic lymphoma (LPL) is a relatively rare form of indolent B-cell non-Hodgkin’s lymphoma, termed Waldenström’s macroglobulinaemia (WM) in the presence of an IgM paraprotein. Although traditionally treated with combination chemoimmuno
Externí odkaz:
https://doaj.org/article/183b06cb93d64b3db975d41a1e86fff2
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-9 (2024)
Abstract Background Waldenström’s macroglobulinemia (WM) is defined as a lymphoplasmacytic lymphoma (LPL) involving the bone marrow (BM) with presence of IgM monoclonal protein, and comprises > 95% of all LPL cases. Rituximab-based regimens have b
Externí odkaz:
https://doaj.org/article/ee1e7a3fc90c49d9b4b6e4f16100db86
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Waldenström macroglobulinemia (WM) is an infrequent variant of lymphoma, classified as a B-cell malignancy identified by the presence of IgM paraprotein, infiltration of clonal, small lymphoplasmacytic B cells in the bone marrow, and the MYD88 L265P
Externí odkaz:
https://doaj.org/article/83e1a80094f944cb857c8ec0a5e73d97
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1353-1361 (2023)
Introduction: Bing-Neel syndrome (BNS) is a rare and heterogenous manifestation of Waldenström macroglobulinemia (WM) involving central nervous system (CNS) infiltration by malignant lymphoplasmacytic cells. Efforts to standardize diagnostic criteri
Externí odkaz:
https://doaj.org/article/65448e94943d411ba6775d300ee220a3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Open Life Sciences, Vol 18, Iss 1, Pp 695-708 (2023)
Waldenström macroglobulinemia (WM) rarely leads to pulmonary embolism. Due to its low incidence, the underlying pathophysiology, prognosis, and optimal treatment remain largely unexplored and uninvestigated. In this study, a patient with a double-cl
Externí odkaz:
https://doaj.org/article/b35dac3898754a14a2a084b3b614be30
Autor:
Karan L. Chohan, Prashant Kapoor
Publikováno v:
Hemato, Vol 4, Iss 2, Pp 135-157 (2023)
Waldenström macroglobulinemia (WM) is a rare, non-Hodgkin lymphoma that remains incurable. Rituximab, an anti-CD20 monoclonal antibody has been the cornerstone of treatment against WM, and its combination with an alkylator, bendamustine, achieves du
Externí odkaz:
https://doaj.org/article/6928ef044f5c4db09847ed4b659b1d83
Autor:
Suraj Shrestha, Elisha Poddar, Bibhav Bashyal, Aayush Adhikari, Prabin Pathak, Suman Acharya, Surendra Sapkota, Anjan Bhattarai, Samriddha Raj Pant, Anjan Shrestha
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-7 (2023)
Abstract Background Waldenström macroglobulinemia is a rare hematological malignancy and is the most common diagnosis in patients with hyperviscosity syndrome. Bilateral central retinal vein occlusion as an initial presentation of hyperviscosity syn
Externí odkaz:
https://doaj.org/article/34a0ddd80ef0498f8407be3ead1214f0
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 731-741 (2022)
Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic disorder characterized by an IgM paraprotein. The clinical presentation of WM varies and can include common manifestations such as anemia and hyperviscosity, in addition to less common f
Externí odkaz:
https://doaj.org/article/df053e0eb31b4eb78e97035deb58a1c0
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 758-770 (2022)
Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenström macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients diagnose
Externí odkaz:
https://doaj.org/article/797bf651db2b47a593055d468100f8a1